| RS2549722965 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2549723925 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS2549723939 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS2549725080 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS2549782519 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549805387 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2549928014 |
TTC19
|
Health Risk |
Likely pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS2549928140 |
TTC19
|
Health Risk |
Likely pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS2549928946 |
TTC19
|
Health Risk |
Likely pathogenic |
— |
| RS2549937925 |
KCNMA1
|
Health Risk |
Likely pathogenic |
KCNMA1-related disorder, KCNMA1-related disorder |
| RS2549940466 |
NBEA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2549948325 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS2549951241 |
TTC19
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS2550006957 |
NBEA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2550008477 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2550010488 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2550073107 |
RALGAPA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2550169186 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2550196133 |
RALGAPA1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency |
| RS2550221031 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2550229446 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2550264308 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2550289323 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS2550305195 |
USP48
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 85 |
| RS2550338285 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2550356690 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550356884 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550384637 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2550438194 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2550438318 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2550438573 |
ZBTB20
|
Health Risk |
Likely pathogenic |
ZBTB20-related disorder, ZBTB20-related disorder |
| RS2550438639 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550438783 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550438849 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550438978 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550439092 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2550439129 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550499110 |
ZBTB20
|
Health Risk |
Likely pathogenic |
— |
| RS2550499342 |
ZBTB20
|
Health Risk |
Likely pathogenic |
— |
| RS2550499377 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2550499967 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550501131 |
MTHFD1
|
Health Risk |
Pathogenic |
— |
| RS2550501254 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2550501344 |
ZBTB20
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2550502656 |
MTHFD1
|
Health Risk |
Likely pathogenic |
— |
| RS2550503069 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2550503155 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2550504926 |
MTHFD1
|
Health Risk |
Likely pathogenic |
— |
| RS2550505030 |
ZBTB20
|
Health Risk |
Pathogenic |
— |
| RS2550505688 |
ZBTB20
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Primrose syndrome |
| RS2550508430 |
MTHFD1
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS2550581823 |
HSPG2
|
Health Risk |
Likely pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS2550601121 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550603288 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550621846 |
HSPG2
|
Health Risk |
Likely pathogenic |
Lethal Kniest-like syndrome, Lethal Kniest-like syndrome |
| RS2550633710 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550658119 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS2550665451 |
HSPG2
|
Health Risk |
Pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS2550675452 |
HSPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2550682749 |
HSPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2550684541 |
CRB2
|
Health Risk |
Pathogenic |
— |
| RS2550684752 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550684781 |
MYT1L
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2550687725 |
CRB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ventriculomegaly-cystic kidney disease, Ventriculomegaly-cystic kidney disease |
| RS2550688194 |
CRB2
|
Health Risk |
Pathogenic |
— |
| RS2550691751 |
ARHGAP5
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2550701604 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550702880 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS2550709678 |
SYNE2
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS2550711719 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550728484 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550748924 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550764807 |
HSPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2550792393 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550794884 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550800597 |
HSPG2
|
Health Risk |
Likely pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS2550801637 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS2550813912 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550814217 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550820203 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2550829388 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2550842376 |
HERC1
|
Health Risk |
Likely pathogenic |
Macrocephaly, dysmorphic facies |
| RS2550858065 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS2550863830 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2550870899 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550897780 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550898220 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550898327 |
MYT1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2550904760 |
HERC1
|
Health Risk |
Pathogenic |
— |
| RS2550905546 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2550910145 |
BRCA1
|
Health Risk |
Pathogenic |
— |
| RS2550916533 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS2550936199 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2550948129 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2550983705 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551001473 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551024138 |
MYT1L
|
Health Risk |
Pathogenic |
MYT1L-related disorder, MYT1L-related disorder |
| RS2551026441 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2551029666 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2551032977 |
SYNE1
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 3, myogenic type |